Scientific publications for BioPredictive non-invasive diagnostics

Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.

11/433 Matches for
“Peripheral arterial disease”

“Peripheral arterial disease” Clear all

  1. Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

    Denimal D et al. · Cardiovasc Diabetol · 2025 Match 100

    …disease (MASLD) are linked to the development of peripheral artery disease. However…

    ActiTest FibroTest NashTest SteatoTest +1

  2. Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease.

    Viglino D et al. · Sci Rep · 2018 Match 96

    Chronic Obstructive Pulmonary Disease (COPD) and Non-Alcoholic Fatty Liver Disease (NAFLD…

    FibroTest NashTest SteatoTest Metabolic

  3. Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea.

    Minville C et al. · Chest · 2014 Match 91

    …factor for nonalcoholic fatty liver disease (NAFLD). NAFLD severity and its implication…

    FibroTest NashTest SteatoTest Metabolic

  4. Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.

    Sène D et al. · Clin Biochem · 2006 Match 87

    ### Objective And Methods We assessed the reliability of non-invasive biological scoring…

    ActiTest FibroTest HCV

  5. Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.

    Jullian-Desayes I et al. · Respirology · 2016 Match 82

    …for non-alcoholic fatty liver disease (NAFLD) occurrence and progression. The impact…

    NashTest SteatoTest Metabolic

  6. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.

    de Lédinghen V et al. · Liver Int · 2012 Match 78

    …liver disease. ### Patients And Methods Consecutive patients with chronic liver disease had…

    SteatoTest Metabolic

  7. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.

    Ahmad W et al. · Virol J · 2011 Match 73

    …The assessment of disease progression not only provides useful information for diagnosis…

    FibroTest HCV

  8. Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.

    Denimal D et al. · Cardiovasc Diabetol · 2024 Match 69

    …and non-alcoholic fatty liver disease (NAFLD) on the other hand are…

    ActiTest FibroTest NashTest SteatoTest +1

  9. Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Key publication

    Shiha G et al. · Hepatol Int · 2009 Match 64

    …of liver fibrosis relevant to disease patterns and clinical practice in the…

    FibroTest SteatoTest HBV HCV +1

  10. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.

    Stevenson M et al. · Health Technol Assess · 2012 Match 60

    …development of alcohol-related liver disease (ALD). Liver biopsy may be used…

    FibroTest Alcohol

  11. Ministère des Affaires Sociales et de la Santé Key publication

    Match 55

    FibroTest HBV HCV

Showing the full result list. The page is server-rendered and not paginated.